Target intelligence / Profile preview

Pseudogene similar to part of stromal antigen 3

Molecular classification
Other, Pseudogene
01

Overview

This locus (ENSG00000170409), referred to as a pseudogene similar to part of stromal antigen 3 (STAG3), is a genomic DNA segment with strong sequence similarity to the STAG3 gene but contains genetic alterations (such as mutations or premature stop codons) that prevent it from producing a functional protein[1][5]. Pseudogenes like this one typically do not encode proteins and are generally considered to lack direct biological function, although growing evidence indicates that some can be transcribed and may regulate the expression of related protein-coding genes via noncoding RNA-based mechanisms (such as competing for microRNA binding, acting as antisense regulators, or modulating transcript stability)[3][4]. However, for ENSG00000170409, there is no documented evidence of it being a therapeutic target, interacting with drugs, serving as a biomarker, or having disease or safety associations. As a pseudogene, it should not be considered a canonical drug target. Key points: - This is a **pseudogene**, not a protein-coding gene or classical drug target[1][5]. - There is nothing to suggest direct involvement in any canonical molecular family (e.g., receptor, enzyme, transporter). - Pseudogenes may occasionally regulate other genes epigenetically or post-transcriptionally[3][4]. - No evidence links this particular pseudogene to drug interactions, biomarkers, or disease association. - It is **incorrect** to refer to this as a validated drug target or functional receptor.

Other names
Pseudogene similar to part of stromal antigen 3 STAG3STAG3 pseudogene
02

Biological functions

Other (Generally considered noncoding; some pseudogenes may regulate gene expression by acting as regulatory RNAs, microRNA decoys, or modulators of parental gene transcript stability, but no specific function is documented for this pseudogene)
03

Disease associations

Other (no direct disease involvement reported for this specific pseudogene; some pseudogenes can influence disease biology via regulatory effects in other contexts[3][4])

Beyond the preview

Go deeper on Pseudogene similar to part of stromal antigen 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of stromal antigen 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call